Avidity Partners Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-529,000	Closed	-$18.8M	–	95
2023 Q4	$18.8M	Sell	529,000 -81,000	-13%	-$2.88M	0.69%	48
2023 Q3	$18.1M	Buy	+610,000	New	+$18.1M	0.73%	51